A major opioid manufacturer that had promised to pay $1.7 billion as compensation over its role in the opioid crisis disclosed on Wednesday that it had reached an agreement with its creditors to reduce the settlement payments by $1 billion.
The funds had been earmarked for addiction victims to rebuild their lives and for governments to pay for priorities like drugs to reverse opioid overdoses.
In a regulatory filing on Wednesday, Mallinckrodt disclosed that it had reached a plan to file for bankruptcy for the second time in three years.
The plan to cancel a majority of the outstanding payments was devised with backing from hedge funds that would control the company under a second bankruptcy.
The funds had lent money to Mallinckrodt and were in a position to force the company to prioritize paying back its lenders over compensating victims.
Persons:
Mallinckrodt
Organizations:
Mallinckrodt Pharmaceuticals